119 related articles for article (PubMed ID: 3968624)
1. Propranolol therapy for portal hypertension in children.
Ozsoylu S; Koçak N; Yüce A
J Pediatr; 1985 Feb; 106(2):317-21. PubMed ID: 3968624
[TBL] [Abstract][Full Text] [Related]
2. Effect of propranolol on hepatic blood flow in normal and portal hypertensive rats.
Hillon P; Blanchet L; Lebrec D
Clin Sci (Lond); 1982 Jul; 63(1):29-32. PubMed ID: 7083761
[TBL] [Abstract][Full Text] [Related]
3. Propranolol for portal hypertension. Evaluation of therapeutic response by direct measurement of portal vein pressure.
Rector WG
Arch Intern Med; 1985 Apr; 145(4):648-50. PubMed ID: 3985727
[TBL] [Abstract][Full Text] [Related]
4. Hemodynamic effect of propranolol on portal hypertension in patients with HBsAg-positive cirrhosis.
Kong CW; Lay CS; Tsai YT; Lee SD; Lai KH; Lo KJ; Chiang BN
Dig Dis Sci; 1986 Dec; 31(12):1303-6. PubMed ID: 3803132
[TBL] [Abstract][Full Text] [Related]
5. Acute effect of propranolol on splanchnic circulation in normal and portal hypertensive rats.
Calès P; Braillon A; Girod C; Lebrec D
J Hepatol; 1985; 1(4):349-57. PubMed ID: 4056347
[TBL] [Abstract][Full Text] [Related]
6. Propranolol--a medical treatment for portal hypertension?
Lebrec D; Nouel O; Corbic M; Benhamou JP
Lancet; 1980 Jul; 2(8187):180-2. PubMed ID: 6105342
[TBL] [Abstract][Full Text] [Related]
7. Hemodynamic effects of chronic tetrandrine and propranolol administration on portal hypertensive rats.
Huang YT; Liu TB; Lin HC; Yang MC; Hong CY
Pharmacology; 1997 May; 54(5):225-31. PubMed ID: 9380768
[TBL] [Abstract][Full Text] [Related]
8. Selective and non-selective beta receptor blockade in the reduction of portal pressure in patients with cirrhosis and portal hypertension.
Westaby D; Bihari DJ; Gimson AE; Crossley IR; Williams R
Gut; 1984 Feb; 25(2):121-4. PubMed ID: 6693039
[TBL] [Abstract][Full Text] [Related]
9. Discrepancy between portal pressure and systemic hemodynamic changes after incremental doses of propranolol in awake portal hypertensive rats.
Koshy A; Girod C; Lee SS; Hadengue A; Cerini R; Lebrec D
Hepatology; 1989 Feb; 9(2):269-73. PubMed ID: 2912829
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the effects of a cardioselective and a nonselective beta-blocker on portal hypertension in patients with cirrhosis.
Hillon P; Lebrec D; Muńoz C; Jungers M; Goldfarb G; Benhamou JP
Hepatology; 1982; 2(5):528-31. PubMed ID: 7118065
[TBL] [Abstract][Full Text] [Related]
11. Acute and chronic hemodynamic effects of propranolol in unselected cirrhotic patients.
Vorobioff J; Picabea E; Villavicencio R; Puccini V; Rossi O; Bordato J; Audano M
Hepatology; 1987; 7(4):648-53. PubMed ID: 3610045
[TBL] [Abstract][Full Text] [Related]
12. Discrepancy between wedged hepatic venous pressure and portal venous pressure after acute propranolol administration in patients with alcoholic cirrhosis.
Valla D; Bercoff E; Menu Y; Bataille C; Lebrec D
Gastroenterology; 1984 Jun; 86(6):1400-3. PubMed ID: 6714569
[TBL] [Abstract][Full Text] [Related]
13. Combined use of propranolol and nifedipine offers better effects on portal vein nonuniform remodeling in carbon tetrachloride (CCl(4))-induced portal hypertensive rats.
Zhang ZQ; Shi B; Wu GQ; Qin KR; Jiang ZL; Zhu L
Eur J Pharmacol; 2009 Jun; 613(1-3):108-13. PubMed ID: 19401196
[TBL] [Abstract][Full Text] [Related]
14. Comparative randomized study on efficacy of losartan versus propranolol in lowering portal pressure in decompensated chronic liver disease.
Agasti AK; Mahajan AU; Phadke AY; Nathani PJ; Sawant P
J Dig Dis; 2013 May; 14(5):266-71. PubMed ID: 23280243
[TBL] [Abstract][Full Text] [Related]
15. Propranolol compared with propranolol plus isosorbide-5-mononitrate for portal hypertension in cirrhosis. A randomized controlled study.
García-Pagán JC; Feu F; Bosch J; Rodés J
Ann Intern Med; 1991 May; 114(10):869-73. PubMed ID: 2014947
[TBL] [Abstract][Full Text] [Related]
16. Damping index of Doppler hepatic vein waveform to assess the severity of portal hypertension and response to propranolol in liver cirrhosis: a prospective nonrandomized study.
Kim MY; Baik SK; Park DH; Lim DW; Kim JW; Kim HS; Kwon SO; Kim YJ; Chang SJ; Lee SS
Liver Int; 2007 Oct; 27(8):1103-10. PubMed ID: 17845539
[TBL] [Abstract][Full Text] [Related]
17. Comparison of three adrenoreceptor blocking agents in patients with cirrhosis and portal hypertension.
Mills PR; Rae AP; Farah DA; Russell RI; Lorimer AR; Carter DC
Gut; 1984 Jan; 25(1):73-8. PubMed ID: 6360815
[TBL] [Abstract][Full Text] [Related]
18. Sympathetic tone modulates portal venous pressure in alcoholic cirrhosis.
Willett IR; Esler M; Jennings G; Dudley FJ
Lancet; 1986 Oct; 2(8513):939-43. PubMed ID: 2877130
[TBL] [Abstract][Full Text] [Related]
19. The effect of propranolol on portal hypertension in patients with cirrhosis: a hemodynamic study.
Lebrec D; Hillon P; Muńoz C; Goldfarb G; Nouel O; Benhamou JP
Hepatology; 1982; 2(5):523-7. PubMed ID: 6981575
[TBL] [Abstract][Full Text] [Related]
20. The hemodynamic effect of verapamil on portal hypertension in patients with postnecrotic cirrhosis.
Kong CW; Lay CS; Tsai YT; Yeh CL; Lai KH; Lee SD; Lo KJ; Chiang BN
Hepatology; 1986; 6(3):423-6. PubMed ID: 3710430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]